2 de diciembre de 2014 / 14:37 / hace 3 años

BUZZ-Biogen Idec Inc: Says Alzheimer's drug shows promise

1 MIN. DE LECTURA

** Biotechnology company's shares up 9 pct at $336.65

** The company says its experimental medicine for Alzheimer's disease showed promise in an early study

** Data strong enough to move into phase 3 trials, company says at Deutsche Bank Biofest

** Up to Monday's close, stock had fallen about 6 pct since Oct. 21, a day before the company reported its Q3 results

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below